Acrobiosystems Co.,Ltd. (SHE:301080)
China · Delayed Price · Currency is CNY 39.67
-0.41 (-1.02%)
At close: Jun 2, 2026
Acrobiosystems Market Cap
Acrobiosystems has a market cap or net worth of 6.63 billion as of June 2, 2026. Its market cap has increased by 16.21% in one year.
Market Cap
6.63B
Enterprise Value
5.40B
Revenue
887.21M
Ranking
n/a
PE Ratio
38.18
Stock Price
39.67
Market Cap Chart
Since October 18, 2021, Acrobiosystems's market cap has decreased from 13.51B to 6.63B, a decrease of -50.89%. That is a compound annual growth rate of -14.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 6.63B | -26.63% |
| Dec 31, 2025 | 9.04B | 71.05% |
| Dec 31, 2024 | 5.28B | -25.26% |
| Dec 29, 2023 | 7.07B | -13.93% |
| Dec 30, 2022 | 8.22B | -51.36% |
| Dec 31, 2021 | 16.89B | 25.06% |
| Oct 18, 2021 | 13.51B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Medicilon | 7.85B |
| Beijing Hotgen Biotech | 7.79B |
| Sino Biological,Inc. | 7.69B |
| Nanjing Vazyme Biotech | 7.61B |
| Innovita Biological Technology | 7.36B |
| Xiangxue Pharmaceutical | 6.56B |
| Jiangsu Aidea Pharmaceutical Group | 6.53B |
| Suzhou Fengbei Biotech Stock | 6.32B |